220
Participants
Start Date
September 23, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2025
Regiocit
"Regiocit can be used as a replacement fluid for CRRT with RCA. It will be used in pre-dilution mode only.~At least 200 mL of post-replacement solution is recommended to minimize clotting in the de-aeration chamber. A replacement/dialysate solution with 22 to 26 mEq/L bicarbonate buffer is advised as the first choice. A higher concentration of bicarbonate may be required in severe cases of acidosis. The use of a non-calcium-containing dialysate or replacement fluid is advised. The rate of administration depends on the targeted citrate dose and the prescribed flow rate. The pre-filter infusion rate of Regiocit will be indexed to the blood flow rate (BFR) to achieve a target blood citrate concentration of 3 to 4 mmol/L. A BFR between 100 to 180 mL/min will be advised; a lower BFR can minimize patient citrate exposure, particularly in patients with lower body weight."
Biphozyl
"Biphozyl is used as a replacement fluid during CRRT. It is injected into the extracorporeal circuit before (pre-dilution) or after (post-dilution) the filter. After the initiation of RRT, Biphozyl is used for late treatment of the acute condition when pH, potassium, and phosphate concentrations return to normal. Biphozyl can also be used if any other buffer is in use or during RCA.~The volume and rate of administration of Biphozyl depend on the blood concentration of phosphate and other electrolytes, acid-base balance, body fluid balance, and overall clinical condition of the patient. The volume of replacement fluid given also depends on the expected intensity (dosage) of treatment."
Prismasol 2
"Prismasol 2 is used as a replacement fluid during CRRT. It is injected into the extracorporeal circuit before (pre-dilution) or after (post-dilution) the filter.~The volume and rate of administration of Prismasol 2 depend on the blood concentration of electrolytes, acid-base balance, fluid balance, and overall clinical condition of the patient. The volume of replacement fluid administered also depends on the required intensity (dosage) of the treatment."
RECRUITING
Beijing Chao-yang Hospital, Capital Medical University, Beijing
RECRUITING
Beijing Anzhen Hospital, Capital Medical University, Beijing
RECRUITING
Xuanwu Hospital Capital Medical University, Beijing
RECRUITING
ZhongShan Hospital Fudan University, Shanghai
RECRUITING
Shanghai East Hospital, Shanghai
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
Zhongnan Hospital, Wuhan University, Wuhan
RECRUITING
The First People's Hospital of Guangzhou, Guangzhou
RECRUITING
Zhujiang Hospital, Southern Medical University, Guangzhou
Vantive Health LLC
INDUSTRY